openPR Logo
Press release

Pemetrexed Diacid Market Forecast by Top Players 2018-2025: Eli Lilly and Company, Fresenius KABI, Teva Pharmaceutical Industries, Dr Reddy’s Laboratories, Abbott Laboratories, Cadila Healthcare Ltd, Accord Healthcare Inc, QILU Pharma Co Ltd, Accure Lab

10-22-2018 09:08 AM CET | Health & Medicine

Press release from: Verified Market Research

Pemetrexed Diacid Market

Pemetrexed Diacid Market

Global Pemetrexed Diacid Market Analysis

According to Verified Market Intelligence, the Global Pemetrexed Diacid Market was valued at USD 3.83 billion in 2017 and is projected to reach USD 6.41 billion by 2025, growing at a CAGR of 6.7% from 2018 to 2025.

What is Pemetrexed Diacid?

With growing pre-disposition towards cancer, people are more alert and looking for solutions that can help cure cancer. Pemetrexed diacid is one such drug approved by the Food and Drug Administration (FDA) to be used in the treatment of cancer in chemotherapy and immunotherapy. It can be used as a supplement or in combination therapy with carboplatin or cisplatin. This drug flourished the pharmaceutical and healthcare industry. Growing adoption of emerging technologies such as advanced analytics, big data, and Internet of Things have contributed in the growth of pemetrexed diacid market.

Get | Download FREE Sample Copy @ https://www.verifiedmarketresearch.com/download-sample/?rid=1519

Global Pemetrexed Diacid Market Outlook

In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and Restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.

Increased reported cases of lung cancer and growing consumption of chemotherapy in developing countries has accelerated the global pemetrexed diacid market. Apart from this, high cost of chemotherapy drug development and effects of pemetrexed diacid might hamper the overall growth rate at a global level.

Verified Market Intelligence narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The “Global Pemetrexed Diacid Market” is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market. This can be of a great use in gaining knowledge about the cutting-edge technologies in the market.

Global Pemetrexed Diacid Market Competitive Landscape

The “Global Pemetrexed Diacid Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as Eli Lilly and Company, Fresenius KABI, Teva Pharmaceutical Industries, Dr Reddy’s Laboratories, Abbott Laboratories, Cadila Healthcare Ltd, Accord Healthcare Inc, QILU Pharma Co Ltd, Accure Labs Pvt. Ltd, Pfizer Inc. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above mentioned players globally.

Ask For Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=1519

Global Pemetrexed Diacid Market Segmentation, by Consumption Type

On the basis of consumption type, Global Pemetrexed Diacid market is segmented into:

In Combination with Cisplatin/Carboplatin
Supplement

Pemetrexed diacid in combination with cisplatin/carboplatin accounted for the major share of the market in 2017 and the demand is projected to expand further over the forecast period.

Global Pemetrexed Diacid Market Segmentation, by Type

On the basis of type, Global Pemetrexed Diacid market is classified into:

Lung Cancer
Liver Cancer
Colorectal Cancer
Stomach
Breast
Others

Lung cancer treatment accounted for the largest share of the market in 2017. This segment is projected to dominate the market over the forecast period.

Global Pemetrexed Diacid Market Segmentation, by Therapeutic Modality

On the basis of Therapeutic Modality, Global Pemetrexed Diacid market is categorized into:

Chemotherapy
Immunotherapy
Other

Chemotherapy held the largest share in this segment in 2017. This segment is also projected to expand at the highest CAGR over the forecast period.

Global Pemetrexed Diacid Market Geographic Scope

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Rest of Europe
Asia Pacific
China
Japan
India
Rest of Asia Pacific
Latin America
Brazil
Rest of the World

In term of geography, Asia Pacific is projected to be the fastest growing region in the global market over the forecast period, owing to growing demand from emerging economies.

Table Of Content

1 Introduction Of The Global Pemetrexed Diacid
2 Executive Summary
3 Research Methodology Of Verified Market Intelligence
4 The Global Pemetrexed Diacid Outlook
5 The Global Pemetrexed Diacid, By Systems
6 The Global Pemetrexed Diacid, By Service
7 The Global Pemetrexed Diacid, By Verticals
8 The Global Pemetrexed Diacid, By Applications
9 The Global Pemetrexed Diacid, By Geography
10 The Global Pemetrexed Diacid Competitive Landscape

Reason to Buy

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pemetrexed Diacid market
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Pemetrexed Diacid market, thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Complete Report is Available @ https://www.verifiedmarketresearch.com/product/global-pemetrexed-diacid-market-size-and-forecast-to-2025/

About Us:
Verified Market Research' has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. Our aim is to save your Time and Resources, providing you with the required Research Data, so you can only concentrate on Progress and Growth. Our Data includes research from various industries, along with all necessary statistics like Market Trends, or Forecasts from reliable sources.

Contact Us:
Mr. Ankush
Call: +1 (650) 781 4080
Email: sales@verifiedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pemetrexed Diacid Market Forecast by Top Players 2018-2025: Eli Lilly and Company, Fresenius KABI, Teva Pharmaceutical Industries, Dr Reddy’s Laboratories, Abbott Laboratories, Cadila Healthcare Ltd, Accord Healthcare Inc, QILU Pharma Co Ltd, Accure Lab here

News-ID: 1317279 • Views:

More Releases from Verified Market Research

[Latest] Republic Of Ireland Renewable Energy Market Key Forecasts and Investment Challenges
[Latest] Republic Of Ireland Renewable Energy Market Key Forecasts and Investmen …
Republic of Ireland Renewable Energy Market: Outlook & Investment Analysis Get | Download Sample Copy with TOC, Graphs & List of Figures @ https://www.verifiedmarketresearch.com/download-sample/?rid=465407&utm_source=Openpr_Oct&utm_medium=316 Q1: What is the current outlook for the renewable energy market in the Republic of Ireland? The renewable energy market in the Republic of Ireland is positioned for strong growth, driven by the government's ambitious targets to achieve 70% renewable electricity by 2030 and net-zero emissions by 2050. Wind
[Latest] Republic Of Ireland Renewable Energy Market Key Forecasts and Investment Challenges
[Latest] Republic Of Ireland Renewable Energy Market Key Forecasts and Investmen …
Republic of Ireland Renewable Energy Market: Outlook & Investment Analysis Get | Download Sample Copy with TOC, Graphs & List of Figures @ https://www.verifiedmarketresearch.com/download-sample/?rid=465407&utm_source=Openpr_Oct&utm_medium=316 Q1: What is the current outlook for the renewable energy market in the Republic of Ireland? The renewable energy market in the Republic of Ireland is positioned for strong growth, driven by the government's ambitious targets to achieve 70% renewable electricity by 2030 and net-zero emissions by 2050. Wind
[Latest] North America Water Enhancer Market Demand Drivers and Investment Options
[Latest] North America Water Enhancer Market Demand Drivers and Investment Optio …
North America Water Enhancer Market: Outlook and Investment Analysis Q1: What is the current outlook for the North America Water Enhancer Market? The North America water enhancer market is experiencing steady growth driven by increasing consumer demand for convenient, flavored, and functional beverages. Rising health consciousness and the preference for low-calorie, sugar-free drinks are fueling market expansion. Innovation in product formulations, including added vitamins, minerals, and electrolytes, is also boosting consumer interest.
[Latest] Myanmar Plastic Market Transition: Challenges and Strategic Value
[Latest] Myanmar Plastic Market Transition: Challenges and Strategic Value
Myanmar Plastic Market Outlook & Investment Analysis What is the current outlook of the Myanmar Plastic Market and its growth potential? The Myanmar plastic market is experiencing moderate but steady growth, driven by rising domestic consumption, urbanization, and industrial expansion. The market size is projected to grow at a CAGR of around 5.2% from 2024 to 2030. Demand is particularly increasing in packaging, construction, and consumer goods sectors. Additionally, government initiatives to

All 5 Releases


More Releases for Pemetrexed

Pemetrexed Injection Market Key Players, Share and Forecast Outlook
"The Pemetrexed Injection Market Is Set To Grow At An Estimated CAGR Of 7.5% From 2025 To 2034, Rising From $1.2 Billion In 2024 To $2.5 Billion By 2034." On May 15, 2025, Exactitude Consultancy., Ltd. released a research report titled "Pemetrexed Injection Market". This report covers the global Pemetrexed Injection market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country,
Pemetrexed Market Share, Growth, And Forecast to 2033 Cadila, Abbott, Eli Lilly
Pemetrexed is a chemotherapy drug primarily used to treat non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. It functions as an antifolate, inhibiting enzymes involved in the synthesis of purines and pyrimidines, which are necessary for DNA and RNA production. This disruption prevents cancer cell proliferation. Pemetrexed is typically given in combination with other chemotherapy agents, like cisplatin, and is administered through an intravenous infusion. It can cause side
Pemetrexed Market Development Trends & Competitive Analysis by Leading Industry …
Allied Market Research added new research on Pemetrexed Market: Global Opportunity Analysis and Industry Forecast, 2022-2029. The Pemetrexed Market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Request The Free Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/10728 Which market perspectives are enlightened in the Pemetrexed Market report? Executive
Huateng Pharma Supplies Intermeidates of Pemetrexed Against NSCLC
Pemetrexed disodium is a drug successfully developed by Eli Lilly in the United States for the treatment of tumors, patent protection to January 2017. Pemetrexed disodium is a multi-targeted anti-folate agent with a core pyrrolopyrimidine moiety in its structure. It is a dual inhibitor of nucleotide synthase/dihydrofolate reductase, which inhibits cell replication by disrupting the normal process of folate-dependent metabolism in cells and simultaneously blocking three different enzyme targets critical
Pemetrexed Disodium API Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Pemetrexed Disodium API market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Pemetrexed Disodium APImarket by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Pemetrexed Disodium APImarket, market definition, overview, industry opportunities
Pemetrexed Market | Eli Lilly and Company, Stada Arzneimittel AG, Eagle Pharmace …
The Pemetrexed market demand is anticipated to flourish during the forecast period 2020-2027. The report offers information related to import and export, along with the current business chain in the market at the global level. This report provides an in-depth overview of the Pemetrexed market. This includes market characteristics, consisting of segmentation, market share, trends and strategies for this market. The Market Size section provides historical forecasts of market growth